Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan Tablets 40 mg USP, 30 tablet bottles, Rx, Only, Distributed by: Acetris Health, LLC, Saddle Brook, NJ, Manufactured by: Aurolife Pharma LLC, Dayton, NJ ---- NDC 52343-122-30

D-1052-2019

March 07, 2019

Class II

Product summary

Firm
Rising Pharmaceuticals, Inc.
Event
Event 82337
Status
Ongoing
Classification
Class II
Quantity
30,530 bottles
Official record key
drug-enforcement:D-1052-2019

Official wording

Reason: CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products

Code information: 470170038A, exp. date 10/31/2019 470180010A, exp. date 02/29/2019 470180012A, exp. date 03/31/2020

Distribution pattern: Product was distributed to 6 major distributors who may have further distributed the product throughout the United States.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity N- nitrosodiethylamine (NDEA
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations